Community Investing Ideas

Global Weekly Picks

CA$31.8
FV
98.8% undervalued intrinsic discount
544
users have viewed this narrative
6users have liked this narrative
1users have commented on this narrative
11users have followed this narrative
US$42.63
39.5% undervalued intrinsic discount
Broke_Joe's Fair Value
Revenue
11% p.a.
Profit Margin
45%
Future PE
25x
Price in 2030
US$113.04
US$223.99
13.8% overvalued intrinsic discount
Revenue
13% p.a.
Profit Margin
20%
Future PE
21x
Price in 2029
US$318.39
PLX logo
Protalix BioTherapeutics

Protalix BioTherapeutics aims for $3.20 by year-end amidst strong revenue growth

As of right now the stock as a current yield of about 2.42%, with a return on equity of about 6.79%. So a bit off of my goals of at least 5% and 10%.Read more

View narrative
264
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
US$4.23
57.2% undervalued intrinsic discount
Zwfis's Fair Value
Revenue
14% p.a.
Profit Margin
20%
Future PE
29.15x
Price in 2028
US$5.11
AU$21.9
4.4% overvalued intrinsic discount
Robbo's Fair Value
Revenue
14.24% p.a.
Profit Margin
12.03%
Future PE
23.34x
Price in 2030
AU$43.53
AU$1.24
0.8% undervalued intrinsic discount
Robbo's Fair Value
Revenue
24.7% p.a.
Profit Margin
21.49%
Future PE
8.51x
Price in 2030
AU$4.91
AU$15
27.9% undervalued intrinsic discount
Robbo's Fair Value
Revenue
24.34% p.a.
Profit Margin
27.08%
Future PE
15.35x
Price in 2030
AU$30.74
NOK 180
52.2% undervalued intrinsic discount
Duffelbag65's Fair Value
Revenue
175.54% p.a.
Profit Margin
3.34%
Future PE
71.47x
Price in 2029
NOK 15.62k
US$38.61
69.4% undervalued intrinsic discount
BlackGoat's Fair Value
Revenue
13% p.a.
Profit Margin
10%
Future PE
28x
Price in 2029
US$76.73